Straits Times Index
3,187.66 +32.97 (+1.05%) S&P 500
5,011.12 -11.09 (-0.22%) Dow
37,775.38 +22.07 (+0.06%) Nasdaq
15,601.50 -81.87 (-0.52%) Bitcoin USD
63,403.17 +2,137.31 (+3.49%) CMC Crypto 200
1,311.43 +425.90 (+48.09%)
JNJ Jun 2024 115.000 put
| Previous close | 0.2400 |
| Open | 0.1300 |
| Bid | 0.1000 |
| Ask | 0.1900 |
| Strike | 115.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.1300 - 0.1300 |
| Contract range | N/A |
| Volume | |
| Open interest | 897 |
ReutersJ&J wins trial over Florida woman who claimed its baby powder caused her cancer
A Florida jury on Thursday concluded that Johnson & Johnson's baby powder talc product did not cause the ovarian cancer of a Florida woman who died in 2019. The lawsuit was brought by family members of Patricia Matthey, a Sarasota County resident who used Johnson's baby powder daily from 1965 until August 2016, when she was diagnosed with ovarian cancer, according to her family's lawsuit. J&J's Worldwide Vice President of Litigation Erik Haas said the company was vindicated by the jury's decision.
ZacksTop Stock Reports for NVIDIA, Alphabet & Johnson & Johnson
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Alphabet Inc. (GOOGL) and Johnson & Johnson (JNJ).
Insider Monkey14 Best Large Cap Dividend Growth Stocks To Buy Now
In this article, we discuss 14 best large-cap dividend growth stocks to buy now. You can skip our detailed analysis of large-cap dividend stocks and their historical performance, and go directly to read 5 Best Large Cap Dividend Growth Stocks To Buy Now. Large-cap stocks have remained ideal for investors as they typically form the […]
